chr13-20189488-G-T
Variant summary
The NM_004004.6(GJB2):c.94C>A (p.Arg32Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The gene GJB2 is a tumor suppressor gene (CancerMine: 5 TSG, 1 oncogene citations). The gene GJB2 is a known oncogene (CancerMine: 5 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000137 (AC=2) in the gnomAD database across 1,461,668 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000742. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.94). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R32H: Pathogenic (ClinVar VariationId 44766, 2 stars)
Frequency
Consequence
NM_004004.6 missense
Scores
Clinical Significance
Conservation
Publications
- Bart-Pumphrey syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- hearing loss disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- ichthyosis, hystrix-like, with hearing lossInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
- keratoderma hereditarium mutilansInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- palmoplantar keratoderma-deafness syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- autosomal recessive nonsyndromic hearing loss 1AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant keratitis-ichthyosis-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, PanelApp Australia
- autosomal dominant nonsyndromic hearing loss 3AInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- KID syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_pathogenic. The variant received 8 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★) | ||
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000007, AC = 2 — absent/extremely rare (O3 moderate [+2]) | ||
| O5Same location/impact as known oncogenic | Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 17 pathogenic, 1 benign (OR vs. background: 58.3); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.44 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_004004.6. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
GJB2 | TSL:1MANE Select | c.94C>A p.Arg32Ser | missense | Exon 2 of 2 | Prot: ENSP00000372299.4 UniProt: | |
GJB2 | TSL:6 | c.94C>A p.Arg32Ser | missense | Exon 1 of 1 | Prot: ENSP00000372295.1 UniProt: | |
GJB2 | c.94C>A p.Arg32Ser | missense | Exon 2 of 2 | Prot: ENSP00000576289.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD2 exomes | AF: 0.00000798 | AC:2 | AN:250496 | ||
GnomAD4 exome | AF: 0.00000137 | AC:2 | Hom:0 | AN:1461668 | Cov:33 |
GnomAD4 genome | Cov:33 | ||||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.00 | 0 | 41958 | 0.0000150 | 1 | 66886 |
SCHEMA | 0.00 | 0 | 67796 | 0.0000150 | 2 | 133082 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 33 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.45 | D |
BayesDel_noAF | Pathogenic | 0.58 | |
CADD | Pathogenic | 27 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.95 | D |
Eigen | Pathogenic | 0.85 | |
Eigen_PC | Pathogenic | 0.70 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -9.2 | |
GPN-Star score | N/A | 9.2 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.68 | D |
MetaRNN | Pathogenic | 1.0 | D |
MetaSVM | Pathogenic | 0.96 | D |
Mutation Taster | N/A | 2/98 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 3.7 | H |
PhyloP100 | Pathogenic | 9.9 | |
popEVE | Benign | -4.0 | |
PrimateAI | Uncertain | 0.60 | T |
PromoterAI | N/A | -0.022 | Neutral |
PROVEAN | Pathogenic | -5.8 | D |
REVEL | Pathogenic | 0.98 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.97 | |
VESM-3B | Benign | -13 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Uncertain | 0.28 | |
Pangolin gain | Uncertain | 0.28 | Position offset: -2 |
SpliceAI score (max) | Benign | 0.13 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.